Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Papillomavirus Infections 1Intestinal Neoplasms 1CIN 2/3 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Artesunate × Clear all
NCT07095309 2025-07-31

NeoART-M

Metanoic Health Ltd.

Phase 2 Not yet recruiting
120 enrolled

Intestinal Neoplasms

NCT07095478 2025-07-31

NeoART-CIN

Metanoic Health Ltd.

Phase 2 Not yet recruiting
28 enrolled

CIN 2/3

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡